Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains ...

Insulet is up 20% since the beginning of the year, and at $308.26 per share, has set a new 52-week high. Investors who bought $1,000 worth of Insulet’s shares 5 years ago would now be looking at ...

On May 30, Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD)’s stock, assigning a “Buy” rating with the price objective of $380.00, as reported by The Fly. The firm’s ...

Insulet (PODD) closed at $177.41 in the latest trading session, marking a -0.34% move from the prior day. The stock's performance was ahead of the S&P 500's daily loss of 0.95%.

NasdaqGS:PODD Return on Capital Employed April 24th 2025. Above you can see how the current ROCE for Insulet compares to its prior returns on capital, but there's only so much you can tell from ...

PODD’s earnings surpassed estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 52.38%. Let’s delve deeper. Upsides for Insulet.

Insulet PODD shares soared 7.2% in the last trading session to close at $264.72. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...